AstraZeneca PLC is 379.1x more valuable than Jade Biosciences, Inc. by market capitalization ($286.27 B vs $755.21 M). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | JBIO | AZN |
|---|---|---|
| Market cap | $755.21 M | $286.27 B |
| US-listed rank | #2665 | #45 |
| Net income (latest FY) | -$127.41M | - |
| SEC filings | 479 | 1,004 |
AstraZeneca PLC is 379.1x more valuable than Jade Biosciences, Inc. by market capitalization ($286.27 B vs $755.21 M).
Full pages: Jade Biosciences, Inc. and AstraZeneca PLC, or browse the full rankings.